Enter your terms above and click the 'Search' button.

Showing articles 0 to 13 of 13 Filter Applied: multiple sclerosis,treatment of (Click to remove) Hemophagocytic Lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab Neurol 90:849-851, Saarela, M.,et al, 2018 Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis NEJM 366:1000-1009, Comi,G.,et al, 2012 Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011 Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010 A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis NEJM 362:387-401, 456, Kappos, L.,et al, 2010 Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis NEJM 355:1124-1140, Kappos,L.,et al, 2006 Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a Neurol 64:888-890, 778, Pohl,D., et al, 2005 Liver Injury Associated with the B-Interferons for MS Neurol 62:628-631, Tremlett,H.L.,et al, 2004 Mitoxantrone Treatment of Multiple Sclerosis Neurol 63(Suppl 6):S28-S32, Cohen,B.A. &Mikol,D.D., 2004 Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management The Neurologist 8:227-236, Frohman,E.,et al, 2002 Fulminant Liver Failure During Interferon Beta Treatment of Multiple Sclerosis Neurol 56:1416, Yoshida,E.M.,et al, 2001 Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999 Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy Neurol 91:e359-e363, Rauer,S.,et al, 2018 Showing articles 0 to 13 of 13